Cadrenal Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2022 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2022 to 2023.
  • Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -2.18 USD/shares, a 116% decline year-over-year.
  • Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.47 USD/shares, a 33.5% increase year-over-year.
  • Cadrenal Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.62 USD/shares, a 27.1% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$0.23 +27.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 -$1 Jan 25, 2022 Dec 31, 2022 10-K 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.